Covid-19: Impact on prescribing and antimicrobial resistance

26Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

Abstract

The onset of the COVID-19 pandemic challenged health-care systems focusing their activity on patients infected with SARS-CoV-2. Previous experience with co-infections and su-perinfections in patients infected with other coronaviruses (SARS-CoV and MERS), the influenza patients admitted to hospitals and prevention of the unknown led to the increased empirical use of broad-spectrum antibiotics in hospitals. The breakdown of antimicrobial stewardship and infection control programs determine an increase in infections due to multi-drug-resistant bacteria, particularly in intensive care units. Most of these infections are related to high-risk carbapene-mase-producing clones and occasionally with resistance to new β-lactam-β-lactamase inhibitor combinations. On the contrary, in the primary care, there has been a decrease in the use of antimicrobials during the first wave, although it would not have had a significant impact on pathogens associated with community-acquired infections. The accumulated experience reaffirms the need to maintain antimicrobial stewardship and infection control programs in future health crises.

Cite

CITATION STYLE

APA

Ruiz-Garbajosa, P., & Cantón, R. (2021). Covid-19: Impact on prescribing and antimicrobial resistance. Revista Espanola de Quimioterapia, 34, 63–68. https://doi.org/10.37201/req/s01.19.2021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free